🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Breast Cancer Risk

Implant-based Breast Reconstruction in Post-bariatric Women - a Registry-based National Study NCT07059104n/a1 site📍 Gothenburg Vastra Gotaland Region · Tests: Breast augmentation, Breast reconstruction after mastectomy A Study of Breast Cancer Risk Factors and Outcomes of People in Florida NCT06780176n/a3 sites📍 Los Angeles📍 Miami📍 New York Memorial Sloan Kettering Cancer Center · Tests: Biospecimen Collection, Surgical Tissue Collection, Survey Collection Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients NCT06722599n/a1 site📍 Beijing Shu Wang A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer NCT07532434n/a1 site📍 Beijing Peking University Third Hospital Genetic Assessment of Breast Cancer Risk in Women in the DORA Programme NCT07734389NA1 site📍 Ljubljana Institute of Oncology Ljubljana · Tests: Comprehensive Clinical and Genetic Breast Cancer Risk Assessment A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks NCT07469709n/a1 site📍 Candiolo Fondazione del Piemonte per l'Oncologia Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer NCT07214532NA49 sites📍 Phoenix📍 Scottsdale📍 Tucson Natera, Inc. · Tests: ctDNA-Guided Treatment Strategy Alcohol, Breast Cancer, and Metabolism NCT07779967NA1 site📍 Urbana University of Illinois at Urbana-Champaign · Tests: Low-alcohol level exposure, Breast-pumping time Single Pre-Operative Radiation Therapy - With Delayed or No Surgery (SPORT-DNS) NCT05217966NA2 sites📍 Montreal📍 Montreal Maisonneuve-Rosemont Hospital · Tests: Radiation: Single Pre-Operative Radiation Therapy Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy NCT05472792Phase 21 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Accelerated Partial Breast Irradiation (APBI), tamoxifen, anastrozole, exemestane, letrozole, fulvestrant, toremifene Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy: Impact of Informing Them of AI-predicted Risk NCT07187726NA27 sites📍 Arras📍 Beuvry📍 Bordeaux UNICANCER · Tests: XAINET AI tool NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III) NCT06081244Phase 343 sites📍 Baden-Baden📍 Böblingen📍 Freiburg im Breisgau Women's Cancer Study Group GmbH · Tests: Sacituzumab govitecan, Pembrolizumab Dalpicilib-Enhanced vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer NCT06637150Phase 31 site📍 Shanghai Fudan University · Tests: Dalpicilib, endocrine therapy Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer NCT07527689NA1 site📍 Shanghai Ruijin Hospital · Tests: Ultra-hypofractionated Regional Nodal Irradiation, Moderate Hypofractionated Regional Nodal Irradiation The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts NCT05667532NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Contrast Enhanced Mammography Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer NCT06757621Phase 31 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Regional Nodal Irradiation Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC NCT06500208Phase 21 site📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: Adebrelimab combined with nab-paclitaxel, epirubicin and cyclophosphamide Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer NCT05658172NA1 site📍 Ulm Prof. Wolfgang Janni · Tests: Determination of tumormarkers (CA27.29, CEA, CA125), Determination of CTC levels, Determination of ctDNA levels, Bioban… NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients NCT06845319Phase 21 site📍 Charleston Medical University of South Carolina · Tests: Carboplatin, Paclitaxel, Pembrolizumab Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer. NCT06364267Phase 21 site📍 Genova Andrea DeCensi · Tests: Tamoxifen 10 MG, Exemestane 25 MG MIBREAST Making in Immediate Breast REconstruction And the Measurement of the EffectS of RadioTherapy NCT07136753n/a1 site📍 London Royal Marsden NHS Foundation Trust Precision Supplemental Imaging in Women With Dense Breasts NCT07277738NA1 site📍 St Louis Washington University School of Medicine · Tests: Prognosia Breast, Mammogram, MRI Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk NCT06557057n/a1 site📍 Rochester Mayo Clinic · Tests: Non-Interventional Study A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation NCT06952803Phase 3346 sites📍 Phoenix📍 Tucson📍 La Jolla AstraZeneca · Tests: Saruparib, Placebo, Abiraterone + Prednisolone/Prednisone, Androgen Deprivation Therapy (ADT) Prophylactic Irradiation to the Contralateral Breast for BCAs Patients NCT04960839NA8 sites📍 Jiangxi📍 Shanghai📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Prophylactic contralateral breast irradiation Pyrotinib in Women With High-risk in Early Stage Breast Cancer NCT05834764Phase 21 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Pyrotinib Olanzapine Based Dexamethasone-sparing Regimen for Breast Cancer Patients With Metabolic-risk Factors NCT07743827NA1 site📍 Alexandria Alexandria University · Tests: Pantoprazole, olanzapine, Dexamethasone Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer NCT07436312NA3 sites📍 Avignon📍 Rennes📍 Villejuif Gustave Roussy, Cancer Campus, Grand Paris · Tests: educational workshop on nutrition + additional intervention on UPF tool and how to use it Older Breast Cancer Patients: Risk for Cognitive Decline NCT03451383n/a1 site📍 Washington D.C. Georgetown University The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer NCT06698679n/a1 site📍 Shenyang Shengjing Hospital · Tests: No intervention
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy